Iris Pharma is a Contract Research Organization ( CRO) specializing in clinical research in ophthalmology. Our clinical trial services bring together an extensive network of professionals with experience in undertaking clinical trials in ophthalmology in Austria, Belgium, Bulgaria, Canada, Czech Republic, Denmark, Eire, France, Finland, Germany, India, Israel, Italy, Morocco, the Netherlands, Norway, Poland, Portugal, Romania, Saudi Arabia, Spain, Switzerland, Tunisia, Turkey, United Kingdom and the USA.
INTERNATIONAL CAPACITIES
|
|
(1) Collaboration with our partner Promedia International
FOCUS ON FRANCE
Iris Pharma has eighteen years of experience in performing clinical trials in France. There are many advantages to conducting clinical trials in France:
- one of the most important markets in ophthalmology in the world
- French ophthalmologists are known to be highly competent
- high quality investigator centers
- French legislation: Huriet-Sérusclat law (20th December 1988) and Loi d´Orientation de Santé Publique (LOSP) number 2004-806 (9th August 2004)
- cost competitiveness compared with other European countries and the USA





